MedAvante-ProPhase Leadership

Serial digital behavioral health CEO. Recent graduate of Stanford's Distinguished Careers Institute Fellow Program and co-founder, former CEO of MedAvante

Steve Downing has more than 25 years of experience in finance and business. Before joining MedAvante, Mr. Downing served as Executive Director of Finance for the Client Support Center of Excellence for Covance. In that position, he led the planning and implementation of a finance reorganization process. Mr. Downing also lent support to responsibility, strategy, capital investment, expansion and financial training. In addition, he led a team responsible for the overall financial health of projects, including profitability, revenue recognition, cash flow, invoicing, and financial training for project managers and their teams. His previous roles at Covance included Global Controller for the Clinical Development Services Business and Senior Financial Analyst for the Corporate office. Before joining Covance, Mr. Downing worked as a Senior Consolidations Analyst with IMO Industries and as an auditor with KPMG Peat Marwick LLP. Mr. Downing has a BS in Accounting and Finance from Trenton State College, and is a Certified Public Accountant.

Dr. Randolph has extensive experience in CNS clinical trials work, as an investigator, consultant and creator and supervisor of rater training programs for a large number of Phase II and Phase III multinational studies in Alzheimer’s disease and other neurodegenerative conditions; schizophrenia; stroke; hepatic encephalopathy; and traumatic brain injury. He also has a strong background and interest in psychometrics and neurocognitive assessment, having worked for over 20 years as a consultant on test development, including the revisions of the Wechsler intelligence and memory scales. He is the author of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), a brief neurocognitive battery used widely around the world. Dr. Randolph is Clinical Professor of Neurology and Director of the Neuropsychology service at Loyola University Medical Center and is board-certified in clinical neuropsychology. He has authored more than 90 peer-reviewed articles on a variety of research interests, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, traumatic brain injury, sport-related concussion, Tourette’s syndrome, schizophrenia and hepatic encephalopathy. Dr. Randolph received an undergraduate degree from Vanderbilt University, and MS and PhD degrees from Rutgers University/University of Medicine and Dentistry of New Jersey. He completed an Intramural Training Award fellowship at the Clinical Brain Disorders Branch of the NIMH, and worked as a senior staff fellow in the Experimental Therapeutics Branch of the NINDS.

Greg Barrett leads worldwide software and platform development for MedAvante-ProPhase, supporting clinical science and signal detection capabilities. He joined the company in April 2017, bringing 30 years of information technology experience. Prior to his current position, Greg was Vice President of IT at the clinical research organization Covance, now a division of LabCorp Holdings. In his role as Global IT Leader for Covance, he oversaw 880 team members supporting five business units with applications, architecture, business engagement and computer systems validation. Before that post, Greg was VP of IT with responsibility for creating and leading Covance’s 400-member global applications and architecture organization, supporting 207 applications and serving all five business units. Greg began his career at AT&T with technical staff assignments as a developer, analyst, architect, project lead and program manager. From there he moved to Computer Sciences Corporation as Director of IT, where he oversaw the development and maintenance arms of the 210-team member AT&T and 110-team member St. Vincent’s Medical Center accounts and supported other accounts including Sun Microsystems, Zurich Insurance, Delphi Automotive, Dunn & Bradstreet, and General Dynamics. He holds a BS degree in Computer Science from Rutgers University and earned an MBA in Finance at Fairleigh Dickinson University.

Steve Herne, an experienced sales and business development executive in both technology and services, joined MedAvante-Prophase as Chief Commercial Officer in July 2017 with overall responsibility for sales and marketing. Prior to his appointment, he was Chief Commercial Officer, eHealth Solutions at Bioclinica, a provider of clinical trial management solutions. Previously, he served as Chief Commercial Officer at clinical trial data and technology company ERT, and Senior Vice President, Global Business Development at Icon Development Solutions. Earlier, he was a Vice President at Covance in the United Kingdom, and a Senior Director at MDS Pharma Services. Herne began his career as a Senior Research Scientist for Inveresk Research before moving to a business development position at Quintiles and then returned to Inveresk as Senior Business Development Manager.

Serial digital behavioral health CEO. Recent graduate of Stanford's Distinguished Careers Institute Fellow Program and co-founder, former CEO of MedAvante